What type of study is this?

September 10, 2025Open Access

Delays and disruptions in cervical cancer care services during the COVID 19 pandemic and their impact on survival outcomes. Real world data from India

View Full Paper

Ask AI

Bookmark

Authors

Retrospective analysis of delays in cervical cancer treatment during COVID-19, revealing worsened survival outcomes.

Delays in cervical cancer care during COVID-19 negatively impacted overall survival outcomes.
In the delay group, the 3-year overall survival was 52% compared to 84% in those without delays.
Treatment delays were identified in 64.1% of patients, with a significant link to tumour upstaging.
Logistic delays were the most common cause, necessitating strategies to mitigate future care disruptions.

Gade et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark